By Neuroscience News
Semaglutide, or Ozempic, a medication used for type 2 diabetes and obesity, may also be effective in treating alcohol dependence.
The drug reduced alcohol relapse drinking and overall alcohol intake in rats by more than half.
Semaglutide acts on the GLP-1 receptor and is taken in tablet form once a week.
Clinical studies are needed to confirm the findings in humans, but the results offer promising insights into potential additional treatment options for alcohol dependence.